The putative metabolic role of d-chiro inositol phosphoglycan in human pregnancy and preeclampsia.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Reproductive Immunology

• Publication date

  2014-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jri.2013.05.006PMID 23962711
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differences in d-chiro-inositol-phosphoglycan expression between first and third trimester human placenta.

  2013cited by this paper
• Activation of NF-κB in Placentas of Women with Preeclampsia

  2012cited by this paper
• Role of lipotoxicity in endothelial dysfunction.

  2012cited by this paper
• Placental expression of D-chiro-inositol phosphoglycans in preeclampsia.

  2012cited by this paper
• Cell oxidant stress delivery and cell dysfunction onset in type 2 diabetes.

  2012cited by this paper
• Free fatty acids induce endothelial dysfunction and activate protein kinase C and nuclear factor-κB pathway in rat aorta.

  2011cited by this paper
• Long-term complications of preeclampsia.

  2011cited by this paper
• Endometrial secretions: creating a stimulatory microenvironment within the human early placenta and implications for the aetiopathogenesis of preeclampsia.

  2011cited by this paper
• Angiogenic factors and preeclampsia.

  2011cited by this paper
• Inositol phosphoglycans and preeclampsia: from bench to bedside.

  2011cited by this paper
• Enhanced Angiogenic Capacity of Human Umbilical Vein Endothelial Cells From Women With Preeclampsia

  2011cited by this paper
• REVIEW ARTICLE: Immunology of Pre‐Eclampsia

  2010cited by this paper
• Pre-eclampsia

  2010cited by this paper
• Obesity, insulin resistance, and pregnancy outcome.

  2010cited by this paper
• D-Chiro-Inositol Glycans in Insulin Signaling and Insulin Resistance

  2010cited by this paper
• Vascular inflammation, insulin resistance, and endothelial dysfunction in salt-sensitive hypertension: role of nuclear factor kappa B activation

  2010cited by this paper
• Vascular actions of insulin with implications for endothelial dysfunction.

  2009cited by this paper
• Endocrine Regulation of Feto-Placental Growth

  2009cited by this paper
• The link between insulin resistance and preeclampsia: new perspectives.

  2009cited by this paper
• The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action

  2009cited by this paper
• Insulin and insulin-like growth factor-I receptors differentially mediate insulin-stimulated adhesion molecule production by endothelial cells.

  2009cited by this paper
• Insulin and the IGF system in the human placenta of normal and diabetic pregnancies

  2009cited by this paper
• Is there a link between insulin resistance and inflammatory activation in preeclampsia?

  2009cited by this paper
• Diabetes and cancer.

  2009cited by this paper
• Fractional Excretion of Tumor Necrosis Factor-&agr; in Women With Severe Preeclampsia

  2008cited by this paper
• Placental Origins of Preeclampsia: Challenging the Current Hypothesis

  2008cited by this paper
• Insulin Signaling Stimulates Insulin Transport by Bovine Aortic Endothelial Cells

  2008cited by this paper
• Nitric Oxide Formation Is Inversely Related to Serum Levels of Antiangiogenic Factors Soluble Fms-Like Tyrosine Kinase-1 and Soluble Endogline in Preeclampsia

  2008cited by this paper
• Preeclampsia, insulin signalling and immunological dysfunction: a fetal, maternal or placental disorder?

  2007cited by this paper
• Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction: Molecular and Pathophysiological Mechanisms

  2006cited by this paper
• Preeclampsia Activates Circulating Immune Cells with Engagement of the NF‐κB Pathway

  2006cited by this paper
• Insulin resistance in human preeclamptic placenta is mediated by serine phosphorylation of insulin receptor substrate-1 and -2.

  2006cited by this paper
• Inositols prevent and reverse endothelial dysfunction in diabetic rat and rabbit vasculature metabolically and by scavenging superoxide.

  2006cited by this paper
• Twenty‐four‐hour urine insulin as a measure of hyperinsulinaemia/insulin resistance before onset of pre‐eclampsia and gestational hypertension

  2005cited by this paper
• Reduced nitric oxide bioavailability contributes to skeletal muscle microvessel rarefaction in the metabolic syndrome.

  2005cited by this paper
• Insulin resistance and preeclampsia in gestational diabetes mellitus.

  2005cited by this paper
• Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production.

  2005cited by this paper
• Latest Advances in Understanding Preeclampsia

  2005cited by this paper
• Intrauterine growth restriction in humans is associated with abnormalities in placental insulin-like growth factor signaling.

  2005cited by this paper
• Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies.

  2004cited by this paper
• Insulin-like growth factor I receptors are more abundant than insulin receptors in human micro- and macrovascular endothelial cells.

  2004cited by this paper
• A physical and functional map of the human TNF-α/NF-κB signal transduction pathway

  2004cited by this paper
• Vascular endothelial cadherin and β-catenin in human fetoplacental vessels of pregnancies complicated by Type 1 diabetes: associations with angiogenesis and perturbed barrier function

  2004cited by this paper
• A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway.

  2004cited by this paper
• Endothelial dysfunction and the metabolic syndrome

  2003cited by this paper
• Protein anabolic effects of insulin and IGF-I in the ovine fetus.

  2003cited by this paper
• The insulin-like growth factors and feto-placental growth.

  2003cited by this paper
• Insulin resistance and its potential role in pregnancy-induced hypertension.

  2003cited by this paper
• Inhibition of Phosphatidylinositol 3-Kinase Enhances Mitogenic Actions of Insulin in Endothelial Cells*

  2002cited by this paper
• Insulin Stimulates Hypoxia-inducible Factor 1 through a Phosphatidylinositol 3-Kinase/Target of Rapamycin-dependent Signaling Pathway*

  2002cited by this paper
• Increased circulating lipid peroxides in severe preeclampsia activate NF‐κΒ and upregulate ICAM‐1 in vascular endothelial cells

  2001cited by this paper
• NF-κB: a key role in inflammatory diseases

  2001cited by this paper
• Inositol phosphoglycans and signal transduction systems in pregnancy in preeclampsia and diabetes: evidence for a significant regulatory role in preeclampsia at placental and systemic levels.

  2000cited by this paper
• Pre-eclampsia

  2000cited by this paper
• Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation

  1999cited by this paper
• Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study.

  1999cited by this paper
• Cell signalling by inositol phosphoglycans from different species.

  1996cited by this paper
• Insulin receptors in syncytitrophoblast and fetal endothelium of human placenta. Immunohistochemical evidence for developmental changes in distribution pattern

  1994cited by this paper
• Inositolphosphoglycan second messengers.

  1994cited by this paper
• Maternal plasma level of endothelin is increased in preeclampsia.

  1991cited by this paper

• Preeclampsia and Obesity—The Preventive Role of Exercise

  2023cites this paper
• Programming of cardiometabolic health: the role of maternal and fetal hyperinsulinaemia

  2022cites this paper
• Myo-Inositol as a Key Supporter of Fertility and Physiological Gestation

  2021cites this paper
• Inositol and antioxidant supplementation: Safety and efficacy in pregnancy

  2019cites this paper
• Clinical utility of thrombophilia, anticoagulant treatment, and maternal variables as predictors of placenta-mediated pregnancy complications: an extensive analysis

  2019cites this paper
• High incidence of early onset preeclampsia is probably the rule and not the exception worldwide. 20th anniversary of the reunion workshop. A summary.

  2019cites this paper
• Preeclampsia as a Form of Type 5 Cardiorenal Syndrome: An Underrecognized Entity in Women’s Cardiovascular Health

  2018cites this paper
• Induction of women with preeclampsia

  2018cites this paper
• Clinical study on the association between pregnancy-induced hypertension and insulin resistance.

  2017cites this paper
• D-chiro inositol phosphoglycans in preeclampsia: Where are we, where are we going?

  2017cites this paper
• Immunological Tolerance, Pregnancy, and Preeclampsia: The Roles of Semen Microbes and the Father

  2017cites this paper
• The "Other" Inositols and Their Phosphates: Synthesis, Biology, and Medicine (with Recent Advances in myo-Inositol Chemistry).

  2016cites this paper
• Die “anderen” Inositole und ihre Phosphate: Synthese, Biologie und Medizin (sowie jüngste Fortschritte in der myo‐Inositolchemie)

  2016cites this paper
• An essay of reflection: Why does preeclampsia exist in humans, and why are there such huge geographical differences in epidemiology?

  2016cites this paper
• Physiological role and clinical utility of inositols in polycystic ovary syndrome.

  2016cites this paper
• Endothelial dysfunction and metabolic syndrome in preeclampsia: an alternative viewpoint.

  2015cites this paper
• Hypoglycemic and hepatoprotective effects of D-chiro-inositol-enriched tartary buckwheat extract in high fructose-fed mice.

  2015cites this paper